CD8(+) T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy.

阅读:3
作者:Kaushik Abhinav, Dunham Diane, Han Xiaorui, Do Evan, Andorf Sandra, Gupta Sheena, Fernandes Andrea, Kost Laurie Elizabeth, Sindher Sayantani B, Yu Wong, Tsai Mindy, Tibshirani Robert, Boyd Scott D, Desai Manisha, Maecker Holden T, Galli Stephen J, Chinthrajah R Sharon, DeKruyff Rosemarie H, Manohar Monali, Nadeau Kari C
While food allergy oral immunotherapy (OIT) can provide safe and effective desensitization (DS), the immune mechanisms underlying development of sustained unresponsiveness (SU) following a period of avoidance are largely unknown. Here, we compare high dimensional phenotypes of innate and adaptive immune cell subsets of participants in a previously reported, phase 2 randomized, controlled, peanut OIT trial who achieved SU vs. DS (no vs. with allergic reactions upon food challenge after a withdrawal period; n = 21 vs. 30 respectively among total 120 intent-to-treat participants). Lower frequencies of naïve CD8(+) T cells and terminally differentiated CD57(+)CD8(+) T cell subsets at baseline (pre-OIT) are associated with SU. Frequency of naïve CD8(+) T cells shows a significant positive correlation with peanut-specific and Ara h 2-specific IgE levels at baseline. Higher frequencies of IL-4(+) and IFNγ(+) CD4(+) T cells post-OIT are negatively correlated with SU. Our findings provide evidence that an immune signature consisting of certain CD8(+) T cell subset frequencies is potentially predictive of SU following OIT.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。